ICCM – icecure medical ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
IceCure Medical Ltd (NASDAQ: ICCM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.50 price target on the stock.
IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America [Yahoo! Finance]
IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America
IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate [Yahoo! Finance]
IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate
Form 20-F IceCure Medical Ltd. For: Dec 31
Form 20-F IceCure Medical Ltd. For: Dec 31
Form 6-K IceCure Medical Ltd. For: Mar 27
Form 6-K IceCure Medical Ltd. For: Mar 20
Form 6-K IceCure Medical Ltd. For: Mar 18
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.